Pharmaceuticals and biotechnology

CFO seats at the roster's 17 companies in this sector, grouped from SIC codes 2834, 2835, 2836, and the CFO moves on the record at them.

Seats filled in this sector · 0% interim

permanent 1interim 0

Industries

EDGAR's own description of each SIC code, with the number of companies.

Newest filing first.

7 weeks ago· 2026-09-01TransitionVRTX

Vertex Pharmaceuticals Incorporated CFO transition: Jonathan Poole to succeed Charles F. Wagner, Jr.

effective 2027-01-01internal promotionsource: sec.gov · Item 5.02

Who holds the seat, from the latest verified filing.

Abbott LaboratoriesABT

CFO: Philip P. Boudreau · verified February 20, 2026

AbbVie Inc.ABBV

CFO: Scott T. Reents · verified February 20, 2026

AmgenAMGN

CFO: Peter H. Griffith · verified February 13, 2026

BIO-TECHNE CorpTECH

CFO not established from filings · checked August 24, 2026

BiogenBIIB

CFO: Robin C. Kramer · verified February 6, 2026

Bristol Myers SquibbBMY

CFO not established from filings · checked February 11, 2026

ELI LILLY & CoLLY

CFO: Lucas Montarce · verified February 12, 2026

Gilead SciencesGILD

CFO: Andrew D. Dickinson · verified February 24, 2026

Idexx LaboratoriesIDXX

CFO: Andrew J. Emerson · verified February 20, 2026

Johnson & JohnsonJNJ

CFO: J. J. Wolk · verified February 11, 2026

Merck & Co., Inc.MRK

CFO not established from filings · checked February 24, 2026

Moderna, Inc.MRNA

CFO: James M. Mock · verified February 20, 2026

PfizerPFE

CFO: David M. Denton · verified February 26, 2026

Regeneron PharmaceuticalsREGN

CFO: Christopher Fenimore · verified February 4, 2026

Vertex PharmaceuticalsVRTX

Change disclosed, effective January 1, 2027 · incoming: Jonathan Poole

Viatris IncVTRS

CFO: Theodora Mistras · verified February 26, 2026

Zoetis Inc.ZTS

CFO: Wetteny Joseph · verified February 12, 2026